| Literature DB >> 31060294 |
Anneleen Baert1, Sofie Pardaens2, Delphine De Smedt3, Paolo Emilio Puddu4, Maria Costanza Ciancarelli5, Amos Dawodu6, Johan De Sutter7, Dirk De Bacquer8, Els Clays9.
Abstract
(1) Background: the main objective of this study was to investigate information needs concerning sexual activity and experienced sexual problems in heart failure (HF) patients and, in addition, to examine the association between these sexual problems and health-related quality of life (HRQoL); (2)Entities:
Keywords: heart failure; need for counselling; quality of life; sexual activity
Mesh:
Year: 2019 PMID: 31060294 PMCID: PMC6539722 DOI: 10.3390/ijerph16091570
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Sample size characteristics.
| Characteristics | Valid % (N) or Mean (SD) | ||
|---|---|---|---|
| Gender ( | Male | 73% (54/74) | |
| Female | 27% (20/74) | ||
| Age, years ( | 62.3 (10.6) | ||
| Country ( | Belgium | 75.7% (56/74) | |
| Italy | 24.3% (18/74) | ||
| NYHA ( | Class I | 13.8% (9/67) | |
| Class II | 72.3% (47/67) | ||
| Class III | 12.3% (8/67) | ||
| BMI a, kg/m² ( | 18.5–25 | 19.4% (13/67) | |
| 25–30 | 45.8% (32/67) | ||
| 30–35 | 16.4% (11/67) | ||
| >35 | 16.4% (11/67) | ||
| Etiology heart failure ( | Ischemic | 50.7% (35/69) | |
| Non-ischemic | 49.3% (34/69) | ||
| LVEF b ( | 33.3 (8.1) | ||
| Medication ( | |||
| Beta blocker | Yes | 93.2% (68/73) | |
| Aldosterone antagonist | Yes | 65.8% (48/73) | |
| ACE inhibitor | Yes | 56.2% (41/73) | |
| ARB c | Yes | 9.6% (7/73) | |
| Diuretics | Yes | 76.7% (56/73) | |
| Ivabradine | Yes | 8.2% (6/73) | |
| Comorbidities and risk factors | |||
| Hypertension d ( | Yes | 55.4% (36/65)) | |
| Hyperlipidemia e ( | Yes | 71.6% (48/67) | |
| Diabetes ( | Yes | 39.7% (27/68) | |
| Patient reported outcomes | |||
| SAS f ( | 5.9 (3.9) | ||
| NSCS-CHF g ( | 2.3 (0.7) | ||
| MLHFQ h ( | 31.6 (20.5) | ||
Continuous variables are presented as mean (SD), while categorical variables are represented by valid% (n). a body mass index, b left ventricular ejection fraction, c angiotensin receptor blockers, d Hypertension (>140/90 mmHg) or medication, e Hyperlipidemia (LDL > 115 mg/dL or medication), f Sexual Adjustment Scale, g Needs for Sexual Counselling Scale in Heart Failure, h Minnesota Living with Heart Failure Questionnaire, NYHA, New York Heart Association, ACE, angiotensin-converting-enzyme.
Comparison between groups for the patient-reported outcomes.
| Independent Variable | Sexual Problems (SAS) | Need for Counselling (NSCS-CHF) | Health-Related Quality of Life (MLHFQ) | ||||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | |||||
| Sex | <0.01 * | 0.01 * | 0.12 | ||||
|
| 6.72 (3.86) | 2.39 (0.68) | 29.39 (20.57) | ||||
|
| 3.79 (3.12) | 1.89 (0.74) | 37.7 (19.87) | ||||
| Age | <0.01 * | 0.74 | 0.48 | ||||
|
| 4.71 (3.84) | 2.23 (0.74) | 30.08 (22.56) | ||||
|
| 7.49 (3.44) | 2.29 (0.72) | 33.47 (17.96) | ||||
| Country | 0.54 | 0.15 | 0.38 | ||||
|
| 5.76 (3.85) | 2.2 (0.72) | 32.82 (21.55) | ||||
|
| 6.47 (4.09) | 2.56 (0.74) | 27.94 (16.88) | ||||
| Beta Blocker generation | 0.79 | 0.87 | 0.19 | ||||
|
| 5.86 (3.85) | 2.25 (0.72) | 32.04 (19.9) | ||||
| Etiology HF | 0.15 | 0.25 | 0.91 | ||||
|
| 6.59 (3.98) | 2.12 (0.82) | 31.43 (22.64) | ||||
|
| 5.18 (3.81) | 2.34 (0.65) | 31.97 (18.03) | ||||
| Hypertension | 0.48 | 0.62 | 0.28 | ||||
|
| 6.27 (4.03) | 2.16 (0.8) | 29.11 (21.27) | ||||
|
| 5.53 (4.03) | 2.27 (0.68) | 34.72 (19.78) | ||||
| Hyperlipidemia | <0.01 * | <0.01 * | 0.17 | ||||
|
| 6.71 (3.91) | 2.37 (0.69) | 33.04 (21.67) | ||||
|
| 3.67 (3.31) | 1.81 (0.68) | 25.58 (13.17) | ||||
| Diabetes | 0.11 | 0.48 | 0.15 | ||||
|
| 6.88 (3.97) | 2.3 (0.77) | 36.04 (23.44) | ||||
|
| 5.26 (3.87) | 2.17 (0.72) | 28.71 (18.01) | ||||
| NYHA | <0.01 * | 0.09 | <0.01 * | ||||
|
| 2.36 (1.6) | 1.73 (0.72) | 20.78 (19.27) | ||||
* significant at p < 0.01 level. HF, heart failure.
Figure 1Experienced sexual problems. * Significant difference based on age at p < 0.01 level; ** significant difference based on age at p < 0.001 level. SAS, sexual adjustment scale.
Figure 2Experienced need for sexual counselling.
Pearson correlation.
| NSCS-CHF | MLHFQ | |
|---|---|---|
|
| 0.17 | |
|
| 0.27 * | 0.39 ** |
* Significant at p < 0.05. ** Significant at p < 0.01.
Multiple linear regression with health-related quality of life (HRQoL) as a dependent outcome variable.
| Independent Variable | Health-Related Quality of Life (MLHFQ) | |||
|---|---|---|---|---|
| Standardized B |
| 95% CI | Adjusted | |
| Sex | 0.31 | 2.37 | 2.11–25.19 | 0.02 |
| Age | −0.01 | −0.06 | −10.78–10.11 | 0.95 |
| NYHA | 0.15 | 1.18 | −1.98–7.7 | 0.24 |
| Sexual problems (SAS) | 0.42 | 3.19 | 0.82–3.58 | <0.01 |
Adjusted R-square of 14.6%.